What Wall Street is watching

What Wall Street is watching

Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in …

Read more

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro …

Read more